Similar Jobs
See allMedical Science Liaison
Freenome
US
Medical Science Liaison
Oncology
Clinical Trial Management
Medical Science Liaison - Southwest
Orca Bio
US
Cell Therapy
Clinical Research
Regulatory Affairs
Pipeline Medical Science Liaison
AbbVie
Clinical Research
Pharmaceutical Industry Knowledge
Communication
Medical Science Liaison (MSL) - Oncology
Natera
US
Oncology
Molecular Diagnostics
Clinical Research
Medical Science Liaison
Not Specified
US
Oncology
Molecular Diagnostics
Clinical Research
Position Overview:
- The Senior MSL is the field-based medical/scientific expert for the company, focusing on engagement with healthcare providers to provide fair/balanced education on investigational products.
- Understands the evolving therapeutic landscape and supports research collaborations across the portfolio.
Responsibilities:
- Identifies, establishes, and maintains collaborative relationships with key investigators, institutions, groups, and consortia in disease state areas of strategic focus.
- Provides education to the medical community on the company’s investigational products and disease areas of focus.
- Increases company visibility and enhances professional interaction with current and future oncology leaders.
Qualifications:
- Minimum five years in Pharmaceutical Industry Medical Affairs as MSL/Sr. MSL; solid tumor experience preferred.
- Advanced degree (M.D., Ph.D., or Pharm.D.) preferred with prior experience in biotech/pharmaceutical or healthcare education.
- Knowledge of treatment guidelines, clinical research processes, FDA regulations, and OIG guidelines.
Company Overview:
- Bicara Therapeutics is a clinical-stage biotech pioneering bifunctional antibodies for targeted tumor modulation.
- Founded in 2020, with over 100 employees globally, headquartered in Boston.
Bicara Therapeutics
Bicara Therapeutics is a clinical-stage biotech company pioneering bifunctional antibodies for targeted tumor modulation. Founded in 2020, the company has a global team of over 100 employees headquartered in Boston, with a focus on advancing its lead asset, ficerafusp alfa.